X @Bloomberg
Bloomberg·2026-03-13 02:12
Sydney hedge fund Regal was dealt a fresh blow after Immutep, an Australian biotech company it backs, wiped out most of its A$582 million ($412 million) market value on Friday when it halted trials of a lung cancer drug https://t.co/i4XrFFN2cS ...